Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
The efficacy of three biochemical methods for the detection of fetal distress was assessed in a prospective study of 224 singleton pregnancies complicated by toxemia. Fetal distress was diagnosed in 65 cases (29 per cent). Abnormally low urinary estriol (E3) excretion pointed out 63 per cent, low serum levels of human placental lactogen (HPL) 27 per cent, and elevated maternal serum alpha fetoprotein (AFP) 10 per cent of distressed fetuses. The efficacy of each test increased with the severity of maternal disease. The frequencies of false pathologic levels were: E3 19 per cent, HPL 0 per cent, and AFP 1 per cent of the cases with a normal fetal outcome. Although E3 was by far the most effective marker, abnormal levels of HPL and AFP provided supportive evidence for fetal distress by pointing out those cases in which E3 reading was not a false positive.
D004461:Eclampsia / Q000378:metabolism; D004964:Estriol / Q000652:urine*; D005189:False Positive Reactions; D005260:Female; D005316:Fetal Distress / Q000175:diagnosis* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D008722:Methods; D009929:Organ Size; D010922:Placenta Diseases / Q000209:etiology; D010928:Placental Lactogen / Q000097:blood*; D011225:Pre-Eclampsia / Q000150:complications / Q000378:metabolism*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000378:metabolism; D000509:alpha-Fetoproteins / Q000378:metabolism*
D000509:alpha-Fetoproteins; D010928:Placental Lactogen; D004964:Estriol